查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032915

非處方藥市場規模、佔有率、趨勢和預測：按產品類型、給藥途徑、劑型、分銷管道和地區分類，2026-2034 年。

Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年全球非處方藥（OTC）市場規模為1873億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以5.02%的複合年成長率成長，到2034年達到2,950億美元。北美目前佔據市場主導地位，預計2025年將佔非處方藥市場佔有率的42.2%。該地區市場成長的促進因素包括消費者強烈的自我治療偏好、較高的醫療保健支出、零售商店的廣泛供應以及對非處方藥的有利監管支持。

非處方成藥無需處方箋或諮詢醫療專業人員即可使用。它們安全有效，可以幫助治療疼痛、咳嗽和感冒、腹瀉、便秘、痤瘡，並緩解反覆發作的偏頭痛和過敏症狀。目前，世界各地的藥局、便利商店、超級市場和加油站均有販售。

非處方藥市場趨勢：

成藥）在治療輕微疾病方面的日益普及是市場成長的主要驅動力。此外，成藥，如制酸劑、組織胺H2受體拮抗劑和質子幫浦阻斷劑（PPI），常用於緩解和預防胃灼熱和胃酸過多。同時，新冠感染疾病提高了大眾對自我護理重要性的認知，導致營養補充品銷售增加，進一步加速了市場成長。領先企業也在拓展產品系列，以擴大基本客群並增加地域覆蓋。此外，越來越多的監管核准從處方藥轉向非處方藥，也對市場產生了正面影響。另一方面，不斷上漲的醫療保健成本促使更多人選擇非處方藥而非就醫。最後，自我治療有助於控制慢性疾病，減少職場缺勤，並避免因輕微疾病而浪費寶貴的醫療資源。其他因素，如全球人口老化、分銷管道的快速擴張以及製藥行業的顯著成長，也在推動整體銷售額和盈利。

市場區隔:

本報告分析了全球非處方藥市場各細分領域的關鍵趨勢，並對2026年至2034年全球、區域和國家的市場進行了預測。報告根據產品類型、給藥途徑、劑型和分銷管道對市場進行了細分。

按產品類型細分：

  • 治療咳嗽、感冒和流感的產品
  • 止痛藥
  • 皮膚科產品
  • 胃藥
  • 維生素、礦物質和補充劑 (VMS)
  • 減重和飲食產品
  • 眼科產品
  • 助眠劑
  • 其他

依給藥途徑細分：

  • 口服
  • 腸外
  • 外用
  • 其他

依劑型分類：

  • 片劑和膠囊
  • 液體
  • 軟膏
  • 其他

按分銷管道細分：

  • 醫院藥房
  • 普通藥房
  • 網路藥房
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

就該產業的競爭格局而言，主要公司包括：Alchem Laboratories Limited、拜耳股份公司、第一三共株式會社、瑞迪博士實驗室、GlaxoSmithKline Plc、強生公司、諾華股份公司、Perigo Company、輝瑞公司、Piramal Enterprises、利潔時集團、賽諾菲、太陽製藥工業公司和梯瓦製藥工業公司。

本報告解答的主要問題

1. 非處方藥（OTC）市場的規模有多大？

2. 非處方藥市場的未來前景如何？

3. 推動非處方藥市場發展的主要因素是什麼？

4. 哪個地區在非處方藥市場中佔有最大的佔有率？

5. 全球非處方藥市場的主要參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球非處方藥市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 治療咳嗽、感冒和流感的產品
  • 止痛藥
  • 皮膚科產品
  • 消化器官系統產物
  • 維生素、礦物質和補充劑 (VMS)
  • 減重和飲食產品
  • 眼科產品
  • 助眠劑
  • 其他

第7章 市場區隔：依給藥途徑

  • 口服
  • 腸外
  • 外用
  • 其他

第8章 市場區隔：依劑型分類

  • 片劑和膠囊
  • 液體
  • 軟膏
  • 其他

第9章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112026A5189

The global over the counter (OTC) drugs market size was valued at USD 187.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 295.0 Billion by 2034, exhibiting a CAGR of 5.02% from 2026-2034. North America currently dominates the over the counter (OTC) drugs market share at 42.2% in 2025. The market in the region is driven by strong consumer preference for self-medication, high healthcare expenditures, widespread retail availability, and favorable regulatory support for non-prescription medications.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market report, along with forecasts at the global, regional and country level from 2026-2034. The report categorizes the market based on product type, route of administration, dosage form, and distribution channel.

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. How big is the over the counter (OTC) drugs market?

2. What is the future outlook of the over the counter (OTC) drugs market?

3. What are the key factors driving the over the counter (OTC) drugs market?

4. Which region accounts for the largest over the counter (OTC) drugs market share?

5. Which are the leading companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2025
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2025
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2025
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million USD), 2026-2034
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players